Company overview

Maxygen (or 'the company') is a biotechnology company engaged in the development of a product candidate for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome. The company operates in the US. It is headquartered in San Mateo, California and employed eight people as on March 01, 2012.

The company recorded revenues of $0.6 million during the financial year ended December 2011 (FY2011), as compared with the revenues of $3.6 million in FY2010. The operating loss of the company was $11.7 million during FY2011, compared with an operating loss of $7.8 million in FY2010. The net profit was $51.4 million in FY2011, a decrease of 25.3% compared with FY2010.

Key facts

NASDAQ National Market ticker: MAXY

No. employees: 8

Turnover: 561,000 (USD)

Financial year end: December

Summary

• Key facts
• Overview
• Business Description
• History
• Key Employees and Biographies
• Location and Subsidiaries
• Top Competitors
• Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

• Provides all the crucial company information required for business and competitor intelligence needs.
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available